Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 27 for “"Patient-derived models"”.
-
Metabolomic Studies of Temozolomide Response in Patient-Derived Models of Glioblastoma
… benefit in this setting. However, over half of patients exhibit intrinsic or acquired resistance and clinical tools remain limited for non-invasive and dynamic therapeutic response assessment. This thesis investigated whether untargeted metabolomic analyses can identify circulating biomarkers …
-
Non-genetic Alterations in Colorectal Cancer Liver Metastasis and Patient-derived Models
… survival rate drops significantly once the patient develops liver metastases. Notably, over the past decade, multiple patient-derived models of cancer (PDMC) have been developed and are widely accepted as preclinical models. Current chemotherapy does not distinguish the primary and …
-
Establishment and molecular characterisation of patient derived models from IDH mutant gliomas
… affect younger adults (20-40 years of age) with patient survival varying between 5-15 years. Lack of appropriate cell and animal based models pose significant challenges to understanding the fundamental biology of LGG and limit drug screening strategies in a quest to find novel therapies. The …
-
Investigating mitochondrial and glycolytic phenotypes in Drosophila and patient derived models of C9orf72 Amyotrophic Lateral Sclerosis
… to glycolysis have been observed in C9orf72-ALS patients and models of the disease. Further understanding of these changes could help the development of new targeted therapies for patients carrying this mutation. This thesis investigates how metabolism is altered in neurones derived from …
-
Exploring the Non-Genetic Reprogramming of Colorectal Cancer and Tumor Microenvironment
… metastasis and the epigenetic remodeling of CRC patient-derived models of cancer. In the study of CRC liver metastasis (Chapter 2), we found that metastatic CRC cells promote their fructose metabolism in the liver by upregulating ALDOB. Knocking down ALDOB or restricting the dietary fructose can …
-
Exploring The Roles Of Long Non-Coding Rnas In Glioblastoma Tumor Recurrence And Therapy Resistance
… a median survival time of around 14 months. Most patients succumb to re-current disease which is often more malignant than the primary tumor and is frequently therapy resistant. There have not been significant advances in the treatment of GBM despite decades of research. This is partly due to the …
-
PARP inhibitors: beyond maintenance therapy
… the significant benefits observed in some patients, expanding the use of PARP inhibitors has proven challenging, especially for those without homologous recombination deficiencies, and for those who develop resistance. These challenges highlight our limited understanding of PARP inhibitors, …
-
Controlling Arrhythmias Using Optogenetic Actuators in Computational Simulations
… stimulation (optogenetics) in computational models of heart cells (cardiomyocytes), cardiac tissues, and heart chambers to control arrhythmia development. Chapter 1 presents an overview of cardiac anatomy, relevant physiology, and cardiac electrophysiology computational models. Chapter 2 …
-
Molecular Biology of Childhood Brain Tumours
… immunotherapies. Next, we establish primary patient derived models of the lethal PFA ependymoma subgroup. Through a series of experiments, we characterize a metabolic-epigenetic axis that drives PFA growth and propose a “Goldilocks Model” of PFA tumorigenesis. Finally, we establish that the …
-
Investigation of Ascites’ Protection of Ovarian Cancer Cells Against Ferroptosis
… cancer (OVCA) and is a primary determinant of patient morbidity and mortality. This process is frequently accompanied by the accumulation of malignant ascites within the peritoneal cavity; however, the role of ascites in shaping metastatic success remains poorly defined. In parallel, emerging …
-
Non-Canonical Regeneration in Acute Myeloid Leukemia
… a unique cell population using relapse models of AML disease in response to chemotherapy and high-resolution single cell transcriptomics. I have termed these cells, regeneration enriched cells (RECs). RECs are devoid of stem cell capacity and contribute to leukemic regeneration through a …
-
Computational Approaches to Delineate Transcriptional and Functional Heterogeneity In Pancreatic Cancer
… CRISPR-Cas9 functional genomics using select models from the cohort. Applying and integrating this novel computational methodology, we integrated CRISPR-based co-dependency annotations with a disease-specific co-expression network developed from patient-derived models to establish a framework …
-
IDH1 R132H Mutations Actively Contribute to the Epigenetic State of Glioma Cells
… mutation-dependent constraints in representative models. Here, we describe and characterize CRISPR-Cas9 based isogenic cell line models using patient-derived IDH1$^{R132H/WT}$ glioma cell lines. We uncover that these models show persistent DNA hypermethylation in CpG loci of the glioma CpG island …
-
An Individualised Medicine Approach to Improve Survival for Patients Diagnosed with Glioblastoma
… at approximately 15 months and less than 5% of patients survive longer than 5 years. Patients harbouring methylation within the MGMT promoter hold a survival advantage. Unfortunately, the majority of GBM patients (~60%) do not harbour a methylated MGMT promoter and treatment options available …
-
Functional genetic screening and therapeutic targeting of recurrent glioblastoma
… (TMZ). Despite these therapeutic efforts, patients succumb to recurrent disease with a median overall survival of 14.6 months and a five-year survival rate of 5.5-6.8%. Therapeutic failure is largely explained by ITH and the presence of treatment-resistant GBM stem-like cells (GSCs). Given …
-
Examining the markers of vitamin C cytotoxicity in pancreatic ductal adenocarcinoma
… Therefore, I created two isogenic cell line models expressing either KRAS G12D or KRAS G12V. Testing depicted increased sensitivity in one model but none others, suggesting that factors beyond oncogenic KRAS alone may be needed to increase sensitivity to vitamin C treatment. Oncogenic KRAS is …
-
Bioengineered 3D In Vitro Strategies to Investigate Phenotypic and Genotypic Differences in Lymphatic Network Sprouting
… dissertation explored bioengineered 3D in vitro models to study lymphatic network sprouting and lymphatic malformations (LMs). Traditional in vivo studies have limitations; however, reproducible tissue-engineered models using primary lymphatic cells offer promising alternatives. Tissue …
-
Pinpointing and targeting novel drivers of pancreatic cancer progression and metastasis using TRAP-seq
… validation. Genetically engineered mouse models (GEMMs) of PC are driven by a KrasG12D mutation and either loss of Trp53 (KPflC; poorly metastatic) or a gain-of-function mutation in Trp53 (Trp53R172H; KPC; highly metastatic). Both GEMMs express GFP-tagged ribosomes specifically in PC …
-
Modelling RANBP2-ALK-rearranged Epithelioid Inflammatory Myofibroblastic Sarcoma
… [1, 2]. This study aimed to generate and utilise models of eIMS to assess molecular-targeted therapeutic combinations to prevent and/or treat ALK inhibitor relapse. Two approaches were pursued to develop clinically relevant eIMS models. Malignant ascites from an eIMS patient at diagnosis and at …
Page 1 of 2